Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that the first prospective validation data for a molecular signature to predict hormone therapy benefit in men ...
NPR

Code Switch

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
IEEE

Complexity-Optimized Sample Selection for Fast Adaptation of Digital Predistorter

Abstract: Sample selection methods have recently achieved success in low-complexity digital predistortion (DPD) parameter identification. However, obtaining appropriate sample sets still requires ...
insider.si.edu

Abstracts of papers, 7th Materials Research Symposium, Oct. 7-11, 1974 : accuracy in trace analysis: sampling, sample handling, and analysis

https://siris-libraries.si.edu/ipac20/ipac.jsp?&profile=liball&source=~!silibraries&uri=full=3100001~!78333~!0#focus ...